On December 30, 2020, the Board of Directors of Mosaic ImmunoEngineering Inc. approved changing the Company’s fiscal year from a fiscal year ending on May 31 to a fiscal year ending on December 31, beginning with the year ending December 31, 2020. The Company will file a transition report on Form 10-K covering the transition period from June 1, 2020 to December 31, 2020, which is the period between the closing of the Company’s most recent fiscal year and the opening date of the Company’s newly selected fiscal year.